Short Description

NGS genetic DNA test detecets for variant and mutation detection in ARL11 gene for Tumor predisposition syndrome, ARL11 related

PreTest Information

Clinical History of Patient who is going for ARL11 Gene Tumor predisposition syndrome, ARL11 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ARL11 Gene Tumor predisposition syndrome, ARL11 related NGS Genetic DNA Test gene ARL11

Detail Description

ARL11 Gene Tumor Predisposition Syndrome: Symptoms, Diagnosis, and Genetic Testing

ARL11 gene tumor predisposition syndrome is a rare genetic disorder that increases the risk of developing tumors. This condition is caused by mutations in the ARL11 gene, which provides instructions for making a protein that helps regulate cell growth and division. When this gene is mutated, cells may grow and divide uncontrollably, leading to the development of tumors.

Symptoms

The symptoms of ARL11 gene tumor predisposition syndrome vary depending on the type of tumor that develops. Some common symptoms include:

• Unexplained weight loss
• Fatigue
• Pain or discomfort in the affected area
• Changes in bowel or bladder habits
• Bleeding or discharge from the affected area

Diagnosis

ARL11 gene tumor predisposition syndrome is diagnosed through a combination of genetic testing, imaging tests, and biopsy. Genetic testing involves analyzing a sample of DNA to look for mutations in the ARL11 gene. Imaging tests such as X-rays, CT scans, and MRI scans can help identify the location and extent of any tumors. Biopsy involves removing a sample of tissue from the affected area and examining it under a microscope to look for signs of cancer.

Genetic Testing

NGS genetic DNA testing is available to identify mutations in the ARL11 gene. This test is performed using a small sample of blood or saliva and can help identify individuals who are at increased risk of developing tumors due to ARL11 gene mutations. The cost of ARL11 related NGS genetic DNA testing in India is INR 20,000.

Conclusion

ARL11 gene tumor predisposition syndrome is a rare genetic disorder that increases the risk of developing tumors. Symptoms of this condition vary depending on the type of tumor that develops. A combination of genetic testing, imaging tests, and biopsy can be used to diagnose this condition. NGS genetic DNA testing can help identify individuals who are at increased risk of developing tumors due to ARL11 gene mutations. If you are concerned about your risk of developing tumors, talk to your doctor about genetic testing.

For more information about genetic testing for ARL11 gene tumor predisposition syndrome, contact DNA Labs India.